Ambeed.cn

首页 / 抑制剂/激动剂 / 抗感染 / Antibacterial / Aminothiazole/2-氨基噻唑

Aminothiazole/2-氨基噻唑 {[allProObj[0].p_purity_real_show]}

货号:A128996 同义名: 氨噻唑 / 2-Aminothiazole; 2-Thiazolylamine

Aminothiazole是一种甲状腺抑制剂,具有抗菌活性,同时也是合成多种生物活性分子的前体化合物。

Aminothiazole/2-氨基噻唑 化学结构 CAS号:96-50-4
Aminothiazole/2-氨基噻唑 化学结构
CAS号:96-50-4
Aminothiazole/2-氨基噻唑 3D分子结构
CAS号:96-50-4
Aminothiazole/2-氨基噻唑 化学结构 CAS号:96-50-4
Aminothiazole/2-氨基噻唑 3D分子结构 CAS号:96-50-4
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Aminothiazole/2-氨基噻唑 纯度/质量文件 产品仅供科研

货号:A128996 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Nat. Electron., 2025, 8, 66-74. Ambeed. [ A100095 ]
Adv. Mater., 2025, 2416621. Ambeed. [ A255324 , A420052 ]
Adv. Mater., 2025, 2410493. Ambeed. [ A838608 ]
Adv. Mater., 2025, 2420319. Ambeed. [ A106129 ]
更多 >

Aminothiazole/2-氨基噻唑 生物活性

描述 Aminothiazole (2-Aminothiazole), a common heterocyclic amine, serves as a precursor in crafting biologically active compounds such as sulfur agents, biocides, fungicides, antibiotics, dyes, and chemical accelerators[1][2].
体外研究

Aminothiazole serves as a thyroid inhibitor in hyperthyroidism research and exhibits antibacterial properties[1].

Aminothiazole is utilized in synthesizing antitubercular and antibacterial agents[3].

Aminothiazole/2-氨基噻唑 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02273219 Uveal Melanoma Phase 1 Active, not recruiting December 2018 United States, Florida ... 展开 >> Bascom Palmer Eye Institute of University Of Miami Medical Center Miami, Florida, United States, 33136 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT02145312 Recurrent or Metastatic Squamo... 展开 >>us Cell Carcinoma of Head and Neck 收起 << Phase 2 Recruiting May 2019 Korea, Republic of ... 展开 >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 03722 Contact: Byung Chul Cho, M.D., Ph.D.    82-2-2228-0880    CBC1971@yuhs.ac 收起 <<
NCT03292250 HNSCC Head an... 展开 >>d Neck Neoplasms 收起 << Phase 2 Recruiting December 31, 2020 Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Bhumsuk Keam, MD    82-2-2072-7215    bhumsuk@snu.ac.kr    Principal Investigator: Hye Ryun Kim          Principal Investigator: Hwan Jung Yun          Principal Investigator: Myung-Ju Ahn          Principal Investigator: Sung Bae Kim          Principal Investigator: Hyun Chang          Principal Investigator: Sang Hoon Chun          Principal Investigator: InSook Woo          Principal Investigator: Yoon Ho Ko          Principal Investigator: Ji Hyung Hong          Principal Investigator: jung hye kwon          Principal Investigator: Heui-june Ahn          Principal Investigator: Yun Gyoo Lee          Principal Investigator: Keonuk Park          Principal Investigator: Eun Joo Kang          Principal Investigator: Seong-Hoon Shin          Principal Investigator: Tak Yun          Principal Investigator: Yoon Hee Choi          Principal Investigator: Keun-Wook Lee          Principal Investigator: Joo-Hang Kim          Principal Investigator: JinSoo Kim          Principal Investigator: Sang-Cheol Lee          Principal Investigator: Hyun Woo Lee          Principal Investigator: Min Kyoung Kim          Principal Investigator: Hyeok Shim          Principal Investigator: Seung taek Lim          Principal Investigator: Kyoung Eun Lee          Principal Investigator: Moon Young Choi          Principal Investigator: Joohan Lim          Principal Investigator: In Gyu Hwang          Principal Investigator: Hyo Jung Kim          Principal Investigator: Jun Eul Hwang          Principal Investigator: Ho Jung An          Principal Investigator: So Yeon Oh          Principal Investigator: Sang-Gon Park          Principal Investigator: Hee Kyoung Ahn          Principal Investigator: Sun Min Lim 收起 <<

Aminothiazole/2-氨基噻唑 参考文献

[1]Gallardo-Godoy A, et al. 2-Aminothiazoles as therapeutic leads for prion diseases. J Med Chem. 2011 Feb 24;54(4):1010-21.

[2]Khalifa ME, et, al. Recent Developments and Biological Activities of 2-Aminothiazole Derivatives. Acta Chim Slov. 2018 Mar;65(1):1-22.

[3]Ran K, et, al. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents. Bioorg Med Chem Lett. 2016 Aug 1;26(15):3669-74.

Aminothiazole/2-氨基噻唑 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

9.99mL

2.00mL

1.00mL

49.93mL

9.99mL

4.99mL

99.86mL

19.97mL

9.99mL

Aminothiazole/2-氨基噻唑 技术信息

CAS号96-50-4
分子式C3H4N2S
分子量 100.14
SMILES Code NC1=NC=CS1
MDL No. MFCD00005325
别名 氨噻唑 ;2-Aminothiazole; 2-Thiazolylamine; NSC 1900; Basedol
运输蓝冰
InChI Key RAIPHJJURHTUIC-UHFFFAOYSA-N
Pubchem ID 2155
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 50 mg/mL(499.29 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 100 mg/mL(998.58 mM)

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。